CME Activities

Expiring Soon: Capturing Consensus and Cutting Out Misconceptions regarding the Aesthetic Skin of Color Consumer

By August 17, 2020September 1st, 2020No Comments

CME Activities

"Capturing Consensus and Cutting Out misConceptions regarding the Aesthetic Skin of Color Consumer"

Who knows what’s best/worst for facial aesthetics in the skin of color patient? No really who? Because there is a great deal of folklore and ballyhoo related to what one can and cannot do, forgetting even what the patients think.
Enter Dr. Andrew Alexis, Professor and Chair of the Department of Dermatology at Mount Sinai St. Luke’s and Mount Sinai West and Director of the Skin of Color Center, with his experienced SOC entourage to marry personal experience and evidence (what a beautiful couple!).
Tune in to hear how it all went down. You couldn’t be in the room where it happened, but after this podcast you might have well been. Learn from one of the greats as I pick his brain on all things, medical and aesthetic, SOC. C to it you don’t miss this podcast.

To receive a CME certificate of participation, you should:

  • Listen to the Podcast Episode here
  • This CME examination requires a 70% pass mark to receive the CME credit and certificate.

Following online completion of the posttest and evaluation, a certificate of participation will be available for download/printing immediately.

Take CME Now

You May Also Like

Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes

| Aesthetics, CME Activities, Featured Articles | No Comments
Earn 1.0 CME Credit: Human facial aging is a gradual and ongoing process involving various factors including photodamage, skin laxity, volume loss of subcutaneous tissue, and bony resorption.1 CME CreditHuman…

Expiring Soon: Capturing Consensus and Cutting Out Misconceptions regarding the Aesthetic Skin of Color Consumer

| CME Activities | No Comments
0.5 CME Credits Who knows what’s best/worst for facial aesthetics in the skin of color patient? No really who? Because there is a great deal of folklore and ballyhoo related…

Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update

| CME Activities | No Comments
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…